Please use this identifier to cite or link to this item:
Title: Potential for Novel Biomarkers in Diabetes-Associated Chronic Kidney Disease: Epigenome, Metabolome, and Gut Microbiome.
Austin Authors: Lecamwasam, Ashani ;Ekinci, Elif I ;Saffery, Richard;Dwyer, Karen M
Affiliation: Epigenetics Group, Murdoch Children's Research Institute, Parkville, VIC 3052, Australia
Department of Medicine, University of Melbourne, Parkville, VIC 3010, Australia
School of Medicine, Faculty of Health, Deakin University, Geelong Waurn Ponds, VIC 3220, Australia
Department of Paediatrics, University of Melbourne, Parkville, VIC 3010, Australia
Issue Date: 10-Sep-2020
Date: 2020-09-10
Publication information: Biomedicines 2020; 8(9): E341
Abstract: Diabetes-associated chronic kidney disease is a pandemic issue. Despite the global increase in the number of individuals with this chronic condition together with increasing morbidity and mortality, there are currently only limited therapeutic options to slow disease progression. One of the reasons for this is that the current-day "gold standard" biomarkers lack adequate sensitivity and specificity to detect early diabetic chronic kidney disease (CKD). This review focuses on the rapidly evolving areas of epigenetics, metabolomics, and the gut microbiome as potential sources of novel biomarkers in diabetes-associated CKD and discusses their relevance to clinical practice. However, it also highlights the problems associated with many studies within these three areas-namely, the lack of adequately powered longitudinal studies, and the lack of reproducibility of results which impede biomarker development and clinical validation in this complex and susceptible population.
DOI: 10.3390/biomedicines8090341
Journal: Biomedicines
PubMed URL: 32927866
ISSN: 2227-9059
Type: Journal Article
Subjects: biomarker
chronic kidney disease
gut microbiome
Appears in Collections:Journal articles

Show full item record

Page view(s)

checked on Sep 28, 2023

Google ScholarTM


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.